A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral soraprazan in Stargardt disease
Latest Information Update: 06 Mar 2023
At a glance
- Drugs Soraprazan (Primary)
- Indications Stargardt disease
- Focus Proof of concept; Therapeutic Use
- Sponsors Katairo
Most Recent Events
- 06 Mar 2023 This trial has been completed in Netherland, according to European Clinical Trials Database record.
- 02 Mar 2023 This trial has been completed in Germany, according to European Clinical Trials Database record.
- 14 May 2019 New trial record